Skip to main content
S&P 5007,811.54+0.59%DOW51,654.95+0.83%NASDAQ27,366.17+0.64%BTC$82,516.00+0.84%ETH$2,488.45+0.36%GOLD$4,220.30+1.52%OIL$91.66+0.19%
Smart Investors Daily
SID Premium
IV

OTC · IVRO

InVitro International

Healthcare · Medical - Diagnostics & Research

$0.06

Up+$0.00 (+0.00%)

Updated Oct 10, 2026, 2:43 PM

SID Score

3.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
2.26M
P/E ratio
18.64
Dividend yield
0.00%
52-week range
$0.03 – $0.16
Volume
1K
Avg. volume
12.21K

Price performance · IVRO

IVRO price history

1M range · 6 trading sessions · Daily adjusted prices

Prices through Oct 2, 2026

IVRO closed at $0.06 after 6 trading sessions, down 14.29% for the selected period.

Last close
$0.06
Period change
-14.29%
Period low
$0.06
Period high
$0.07
Daily close
View OHLC price history
IVRO OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 2, 2026$0.06$0.06$0.06$0.061K
Oct 1, 2026$0.065$0.065$0.065$0.0654.1K
Sep 17, 2026$0.06$0.06$0.06$0.065K
Sep 16, 2026$0.06$0.06$0.06$0.067K
Sep 15, 2026$0.074$0.074$0.06$0.06216
Sep 11, 2026$0.06$0.07$0.06$0.0757.89K

Latest IVRO news

The latest Smart Investors Daily articles mentioning IVRO.

Stock researchCompany · Overview

IVRO research

Overview

Company profile and research snapshot.

Company profile

INVITRO INTL

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Dec 9, 2025

Game Changing Signals from Global Regulatory Agencies Accompany IVRO Sales and Profit Gains

Placentia, California--(Newsfile Corp. - December 9, 2025) - Today, InVitro International (OTCQB: IVRO) reported FY '25 sales of $878,937, up 8.3% over FY '24. Net income of $121,980 advanced 14.3% for the same period. CEO and Chairman, W. Richard Ulmer, offered his view of IVRO's progress: "In this past year, Regulatory Agencies around the world announced they have already, or will soon, cease funding for animal testing; some have stopped now. Further, some RA's state OECD validated NON-animal.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By